Mason Freeman

Professor of Medicine

United States

56 investments

Mason Freeman is a Professor of Medicine at Massachusetts General Hospital based in United States. Mason Freeman has backed 56 companies, including Precision NanoSystem, Vor Biopharma and Aprea. Investment focus areas include Health Care, Hospitals and Genetics.

Investment Focus

Portfolio Companies (56)


1	Precision NanoSystem
2	Vor Biopharma
3	Aprea
4	Arvinas
5	GenePeeks
6	RareCyte
7	Portal Instruments
8	Entrada Therapeutics
9	Ceterix Orthopaedics
10	Audentes Therapeutics
11	CinCor Pharma
12	Homology Medicines

Showing 1–12 of 56

Page 1 of 5

Access Full Contact Information

Get Mason Freeman's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

Portfolio

3-day free trial, cancel anytime

Raising a round? Run your numbers first

Free tools founders use before pitching investors like this one.

Runway calculatorHow long your cash lasts Burn rate calculatorMonthly spend, gross and net Funding goal calculatorHow much to raise Investor ROI calculatorWhat your investors earn Pitch deck template11 slides that close Fundraising playbookThe 7-step raise process